Medicine and Dentistry
Aerobic Glycolysis
11%
Antiangiogenic Therapy
6%
Assisted Reproductive Technology
11%
Biopsy
11%
Birth Outcomes
11%
Blood Flow
10%
Breast Carcinoma
6%
Cancer Therapy
17%
Cancer Tissue
7%
Cervical Cancer
11%
Combretastatin
11%
Combretastatin A-4
11%
Computer Assisted Tomography
11%
Contrast Medium
8%
Diffusion MRI
5%
Dynamic Contrast-Enhanced MRI
30%
Female Genital Tract Cancer
11%
Flow Measurement
7%
Folic Acid
6%
Hyperpolarized Magnetic Resonance Spectroscopy
7%
Hyperthermia
11%
Lactic Acid
5%
Magnetic Resonance Imaging
40%
Magnetic Resonance Imaging
11%
Malignant Neoplasm
30%
Microvessel
10%
Model Selection
11%
Nanoparticle
11%
Neoplasm
100%
Nuclear Magnetic Resonance Spectroscopy
11%
Odds Ratio
7%
Phospho Soda
9%
Photoelectric Plethysmography
34%
Plinabulin
11%
Premature Labor
8%
Radioactive Tracer
13%
Sarcoma
5%
Skin Carcinoma
34%
Spatial Analysis
11%
Squamous Cell Carcinoma
20%
Surgery
7%
Tumor Blood Flow
11%
Tumor Hypoxia
11%
Tumor Physiology
11%
Tumor Vascularization
9%
Vascular Network
5%
Vascular-Targeting Agent
17%
Vascularity
13%
Pharmacology, Toxicology and Pharmaceutical Science
Azure A
11%
Breast Carcinoma
7%
Combretastatin
22%
Combretastatin A4
40%
Contrast Medium
16%
Cyclooxygenase 2
5%
Disodium Hydrogen Phosphate
29%
Folate Receptor
5%
Folic Acid
18%
Indocyanine Green
5%
Iron Oxide Nanoparticle
11%
Kidney Injury
11%
Malignant Neoplasm
24%
Model Selection
11%
Mouse
5%
Nanoparticle
24%
Neoplasm
72%
Perfluorooctyl Bromide
14%
Plinabulin
11%
Poloxamer
11%
Polyglactin
14%
Premature Labor
5%
Small Interfering RNA
11%
Superparamagnetic Iron Oxide Nanoparticle
11%
Tracer
13%
Tumor Model
18%
Uterine Cervix Cancer
11%
Vascular Targeting Agent
10%
Immunology and Microbiology
Aerobic Glycolysis
11%
Angiogenesis
13%
Antineoplastic Activity
11%
Computer Assisted Tomography
11%
Contrast Medium
13%
Granulocyte
5%
Magnetic Resonance Imaging
57%
Magnetism
11%
Mouse
7%
Murine
13%
Neutrophil
11%
Neutrophil Granulocyte
7%
Preclinical Study
11%
Squamous Cell
13%
Tumor Vascularization
9%
Videorecording
6%
